Search Articles

View query in Help articles search

Search Results (1 to 2 of 2 Results)

Download search results: CSV END BibTex RIS


Noninvasive, Multimodal Inflammatory Biomarker Discovery for Systemic Inflammation (NOVA Study): Protocol for a Cross-Sectional Study

Noninvasive, Multimodal Inflammatory Biomarker Discovery for Systemic Inflammation (NOVA Study): Protocol for a Cross-Sectional Study

Fecal calprotectin is a well-established biomarker for inflammatory bowel disease, yet its clinical relevance to other inflammatory diseases remains largely unexplored [10]. Recent studies have shown encouraging results including significant associations with serum calprotectin in patients with spondyloarthritis compared with matched controls and increased serum calprotectin levels correlated with disease activity in both rheumatoid arthritis and axial spondyloarthritis [11,12].

Jinjoo Shim, Sinziana Muraru, Rucsandra Dobrota, Elgar Fleisch, Oliver Distler, Filipe Barata

JMIR Res Protoc 2024;13:e62877

An Intervention With Michigan-Grown Wheat in Healthy Adult Humans to Determine Effect on Gut Microbiota: Protocol for a Crossover Trial

An Intervention With Michigan-Grown Wheat in Healthy Adult Humans to Determine Effect on Gut Microbiota: Protocol for a Crossover Trial

The secondary outcome measure will be biomarkers of gastrointestinal inflammation, as measured by protein concentrations of calprotectin and lipocalin-2 in protein extracts of the stool samples. Furthermore, the microbiota beta diversity, abundance of Bifidobacterium and Lactobacillus, and butyrate production capacity of the gut microbiota will be assessed after each week of treatment. The abundance of Bifidobacterium and Lactobacillus will be determined from the sequencing results.

Gigi A Kinney, Eliot N Haddad, Linda S Garrow, Perry K W Ng, Sarah S Comstock

JMIR Res Protoc 2021;10(10):e29046